HCPCS Implementation Checklist for 2026

HCPCS Update

HCPCS Level II & CMS Guidelines

HCPCS January 2026 Update: Includes 160 new codes and 101 deletions. Notable additions include new J-codes for FDA-approved products and M-codes for telehealth-conducted encounters.

CMS Terminology Shift: CMS is beginning to phase out the term “Social Determinants of Health” in favor of “upstream drivers” in certain official descriptors.

NCCI Policy Revisions: As of January 1, 2026, 3D rendering (e.g., 76376) may no longer be reported specifically for mapping sites of multiple biopsies under radiologic guidance.

 Checklist for 2026

    1. Update Charge Masters: Ensure all deleted LER and MS codes are replaced to avoid immediate denials.
    2. Audit Remote Monitoring: Update workflows to capture 10-minute treatment management thresholds.
    3. Document AI Use: Ensure medical records specify if augmentative AI software was used for cardiology or imaging interpretations.

1. Key Behavioral Health & Telehealth G-Codes

New codes facilitate better integration and monitoring of mental health services:

    • G0568–G0570: New codes for Psychiatric Collaborative Care Management (CoCM) and Behavioral Health Care Planning.
    • G0660–G0668: A new series for TEAM remote evaluation and management (E/M) services, aligning with current outpatient E/M timeframes (e.g., G0660 for 10 minutes, G0664 for 60 minutes).
    • G9871: A specific code for online diabetes prevention behavioral counseling (60 minutes).
    • M1426, M1431, M1436+: New M-codes specifically to identify encounters conducted via telehealth across various specialties.

2. Medical Supplies & Catheter Updates (A-Codes)

CMS has phased out generic catheter coding in favor of more specific classifications:

    • A4295: Intermittent urinary catheter; straight tip, hydrophilic coating.
    • A4296: Intermittent urinary catheter; coude (curved) tip, hydrophilic coating.
    • A4297: Intermittent urinary catheter; hydrophilic coating, with insertion supplies.

3. New Injectable Drugs & Biosimilars (J & Q Codes)

A significant portion of the 160 new codes are found in the J and Q sections for advanced therapies:

    • J0013: Esketamine nasal spray, 1 mg (replaces discontinued S0013).
    • J1073: Testosterone pellet, implant, 75 mg (replaces discontinued S0189).
    • J3387: Injection, elivaldogene autotemcel, per treatment.
    • Q5160: Injection, bevacizumab-nwgd (Jobevne), biosimilar, 10 mg.
    • Q4411: AmnioMatrixF4X, human cell/tissue cover for wounds.

4. Remote Monitoring & Management Refinements

While foundational codes remain, 2026 adds flexibility for management:

    • Reduced Management Thresholds: New guidelines allow billing for just 10 minutes of clinical monitoring (e.g., CPT 99470) instead of the previous 20-minute minimum.
    • Short-Term Monitoring: New codes (such as CPT 99445) cover 2–15 days of reading per month, offering an alternative to the standard 16-day requirement for device supply.

5. Terminology & Administrative Changes

    • “Upstream Drivers”: CMS is officially phasing out the term “Social Determinants of Health” (SDoH) in descriptors (e.g., for codes G2076 and G2077) and replacing it with “upstream drivers”.
    • Permanent Telehealth: CMS has removed the distinction between “provisional” and “permanent” services on the Medicare telehealth list; all added services are now considered permanent.

HCPCS Level II updates include critical drug code crosswalks and the implementation of new specialty-specific MIPS Value Pathway (MVP) codes.

1. Discontinued J-Code Crosswalks (Effective Jan 1, 2026)

CMS has deleted several long-standing J-codes, often replacing them with more specific permanent codes or standardizing temporary S-codes into the J-series.

HCPCS
Discontinued Code  Description Replacement/Crosswalk Code
S0013 Esketamine nasal spray J0013 (Esketamine, 1 mg)
S0189 Testosterone pellet implant J1073 (Testosterone pellet, 75 mg)
C9174 Datopotamab deruxtecan J9011 (Injection, 1 mg)
C9175 Treosulfan J0614 (Injection, 50 mg)
J9098 Cytarabine liposome Deleted (No direct crosswalk provided)
J9019 Erwinaze injection Deleted (No direct crosswalk provided)
J9020 Asparaginase, NOS Deleted (No direct crosswalk provided)
J8650 Nabilone, oral Removed from coverage direction

 2. MIPS Value Pathway (MVP) Codes (M1498–M1503)

CMS introduced a series of M-codes specifically to identify clinicians or groups participating in MIPS Value Pathways. These codes are used for administrative tracking of quality and cost performance within specific clinical specialties.

    • M1498: Diagnostic Radiology MIPS Value Pathway
    • M1499: Interventional Radiology MIPS Value Pathway
    • M1500: Neuropsychology MIPS Value Pathway
    • M1501: Pathology MIPS Value Pathway
    • M1502: Podiatry MIPS Value Pathway
    • M1503: Vascular Surgery MIPS Value Pathway

3. Notable Telehealth & Quality M-Codes

    • M1426, M1431, M1436+: Broad set of codes to identify encounters conducted via telehealth across different clinical scenarios.
    • M1482–M1485: New codes for tracking Hepatitis C treatment outcomes, specifically achieving “sustained virological response”.
    • M1492–M1497: Specific codes for Falls Risk Management, differentiating between patients who reported a fall and those with a documented plan of care.

4. Administrative Reminders

    • No Grace Period: Codes discontinued on December 31, 2025, are invalid for 2026 dates of service. Claims using deleted codes for services provided in January 2026 will be denied.